Citadel Advisors
HAO icon

Citadel Advisors’s Haoxi Health Technology Ltd HAO Stock Holding History

Citadel Advisors’s Portfolio HAO Stock Details HAO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-104
Closed -$15.9K – 14305
2025
Q3 		$15.9K Sell
104
-11
-10% -$1.79K ﹤0.01% 12524
2025
Q2 		$18.8K Buy
+115
New +$19.5K ﹤0.01% 12115

Other funds holding HAO

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citadel Advisors's HAO Position: Q4 2025 in Review

Citadel Advisors sold out of Haoxi Health Technology Ltd (HAO) in Q4 2025, closing a stake of 104 shares — an estimated $15.9K sold.

Citadel Advisors first reported a position in HAO in Q2 2025 and held it in 2 quarters. The position peaked at $18.8K in Q2 2025. 4 funds tracked by Wall St. Rank hold HAO as of Q4 2025.

  • Citadel Advisors reported no remaining Haoxi Health Technology Ltd position as of Q4 2025 after selling out during the quarter.
  • Citadel Advisors sold 104 Haoxi Health Technology Ltd shares in Q4 2025, an estimated $15.9K.
  • Citadel Advisors first reported a position in Haoxi Health Technology Ltd in Q2 2025 and held it in 2 quarters.
  • Citadel Advisors's Haoxi Health Technology Ltd position peaked at $18.8K in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Haoxi Health Technology Ltd as of Q4 2025.

Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.